Market Overview

Morning Market Movers

Related CYTR
Morning Market Movers
CytRx Reports Positive Results from Global Phase 2b Clinical Trial with Aldoxorubicin in Advanced Soft Tissue Sarcomas
Related DM
Stocks Hitting 52-Week Lows
Stocks Hitting 52-Week Lows

CytRx (NASDAQ: CYTR) rose 29.55% to 2.85 after the company reported that aldoxorubicin demonstrated statistically significant efficacy in the treatment of rapidly growing human brain cancer brains animals.

The Dolan Company (NYSE: DM) shares jumped 16.67% to $2.07 after the company announced its plans to sell two NDeX businesses.

Ambient (NASDAQ: AMBT) jumped 9.79% to $3.14 after the company reported that it has been awarded contract by Consolidated Edison.

WD-40 Company (NASDAQ: WDFC) moved up 8.71% to $62.67 on upbeat FQ3 earnings.

Posted-In: Morning Market MoversNews Intraday Update Markets

 

Most Popular

Related Articles (CYTR + AMBT)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free